Dr. Joanie Mayer Hope, MD

Dr. Hope practices at Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services.

Dr. Hope's NPI, 1265651053, was assigned on April 24, 2007. Dr. Hope graduated from State University of New York Downstate Medical Center in 2006. Dr. Hope holds Alaska license 6937.

Dr. Hope's primary practice is Providence Alaska Medical Center, at 3200 Providence Drive, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-2211.

Dr. Hope's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. Dr. Hope is also affiliated with Alaska Native Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Hope to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hope practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Hope's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Hope is licensed in Alaska.

CMS data shows 339 Medicare services from Dr. Hope across 6 procedure codes in 2024, for 191 Medicare patients. Medicare paid $63,432 for them.

CMS counts 191 Medicare patients who saw Dr. Hope in 2024. The largest group is 65 to 74, with 105 patients. 66% of them have high blood pressure, and 57% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hope's median patient age at 68, with 100% women.

In 2024, Dr. Hope wrote 581 Medicare Part D claims for 102 patients. 74% of them were for generic drugs. CMS names the drug for 406 of them, across 14 drugs with 11 or more claims each, at $711,372 in total drug cost. In 2023, CMS named 483 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hope for performance year 2024, reported as part of a group. Dr. Hope accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hope as offering telehealth. CMS counts 30 procedures of removal of the uterus by Dr. Hope, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Hope, published from 2013 to 2025. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols and Carboplatin. Dr. Hope's most frequent co-authors are Mark S. Shahin, MD, Carol Aghajanian, MD and Lindsey B. Beffa, MD.

Dmand AI links Dr. Hope to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms and Ovarian Diseases.

CMS Open Payments shows 78 general payments to Dr. Hope from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Intuitive Surgical, Inc. paid the most, $3,112.

Dr. Hope graduated from State University of New York Downstate Medical Center in 2006.